Cumberland Pharmaceuticals (CPIX) Stock Forecast, Price & News

Cumberland Pharmaceuticals' stock was trading at $2.25 at the beginning of the year. Since then, CPIX stock has decreased by 20.4% and is now trading at $1.79.
View the best growth stocks for 2023 here.

Cumberland Pharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 21,300 shares, an increase of 13.3% from the August 31st total of 18,800 shares. Based on an average daily trading volume, of 20,500 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.3% of the shares of the company are short sold.
View Cumberland Pharmaceuticals' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our CPIX earnings forecast.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released its quarterly earnings results on Tuesday, August, 8th. The specialty pharmaceutical company reported $0.15 EPS for the quarter. The specialty pharmaceutical company earned $10.89 million during the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 11.44% and a negative net margin of 4.39%.

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CPIX stock can currently be purchased for approximately $1.79.

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a market capitalization of $25.72 million and generates $42.01 million in revenue each year. The specialty pharmaceutical company earns $-5,570,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is www.cumberlandpharma.com. The specialty pharmaceutical company can be reached via phone at (615) 255-0068, via email at investors@cumberlandpharma.com, or via fax at 615-255-0094.